Innovation Pharmaceuticals Inc (IPIX)

[sunspotter]

"Thanks I am not sure why anyone would argue about soc"

To be clear I am merely suggesting that remesdivir is not standard of care. Dexamethasone clearly is, for some patients at least.

The study design should be a (pre-defined) standard of care plus placebo vs each arm of trial drug plus placebo plus standard of care.

It's important that the patients and investigators are unaware of which intervention they have been given, hence the need for a real physical placebo.